Indoco Remedies Ltd. - Employees, Business, Industry & CEO

Indoco Remedies Ltd. was founded in 1947.

Govind Ramnath Kare is the founder of Indoco Remedies Ltd..

Indoco Remedies Ltd. generates $147.3M in revenue.

Indoco Remedies Ltd. headquarters are in Mumbai, Maharashtra, India.

Indoco Remedies Ltd. has 4526 employees.

Indoco Remedies Ltd. is in pharma sector.

Yes, Indoco Remedies Ltd. is a public company.

Indoco remedies ltd., headquartered in mumbai, is a fully integrated, research-oriented pharma company with presence in 55 countries. indoco, a usd 161 million company, employs over 5500 people including 300 skilled scientists. the company has 9 manufacturing facilities, out of which 6 are for finished dosages and 3 for apis, supported by a state-of-the-art r&d centre at rabale, navi mumbai. the facilities have been approved by various regulatory authorities such as, usfda, uk-mhra, sukl-czech republic, cofepris – mexico, tga-australia, jazmp- slovenia, mcc-south africa, nda-uganda, tfda-tanzania, sbd-yemen, moh-ukraine, ppb-kenya and fda-ghana. indoco develops, manufactures and distributes a wide range of pharmaceutical products for the indian and international markets. it generates more than 70 million prescriptions annually from over 3,10,000 doctors in india. indoco’s 9 domestic marketing divisions cater to different therapeutic segments, including respiratory, anti-infectives, dental care, pain management, gastroenterology, opthalmic, cardiovascular, anti-diabetics, anti-obesity, etc. top indoco brands include cyclopam, febrex plus, sensodent-k, atm, oxipod, cital, sensoform, cloben-g, sensodent – kf, karvol plus, glychek, vepan, tuspel plus, flamar, etc. indoco has carved a place for itself in the international arena and is exporting a number of generic products in the regulated and emerging markets. the company’s products are distributed in over 55 countries across the globe, including usa and eu. indoco’s branded formulations are promoted in emerging markets of south east asia, africa, latin america and cis countries. the company participates in various tenders floated by authorities from different countries. indoco has major tie-ups with big generic companies and works in close coordination with its customers for leveraging core competencies. anacipher, indoco’s analytical service division has been carved to serve customers for their analytical research needs, utilizing the state-of-the-art instruments/infrastructure and highly experienced human resources. xidel offers end–to-end engineering and consulting services to all phases of project development, right from project design to validation. xidel has been providing these services to the pharmaceuticals & api sector for the past 15 years and has completed several, which are now award winning & internationally approved facilities that produce high quality products efficiently and economically. anacipher cro, based in hyderabad, is a gdufa (usfda) registered clinical research facility and is spread over 30,000 sq. ft area and staffed by experienced professionals providing clinical trial solutions, including bioavailability and bioequivalence (ba/be)/phase i/phase ii studies for pharmaceutical companies globally. the cro has successfully completed more than 450 studies in multiple therapeutic areas such as, cardiovascular, diabetes, oncology, anti-retrovirals and antacids. with one foot firmly entrenched in the fast growing indian pharma market and the other in the vast international market, indoco is beautifully poised to achieve greater heights.

Indoco Remedies Ltd. specialises into Pain Management, Respiratory, Anti-infectives, Dental Care, Gastroenterology, Ophthalmic, Anti-diabetics, Anti-obesity

Govind Ramnath Kare